Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders?

Thrombosis Research
David Bevan

Abstract

Congenital abnormalities of fibrinogen are rare disorders classified as quantitative (afibrinogenemia and hypofibrinogenemia) or qualitative types (dysfibrinogenemia and hypodysfibrinogenemia). Fibrinogen is essential to haemostasis as the substrate for fibrin clot formation and also acts in primary haemostasis as a key ligand in platelet aggregation. Quantitative deficiency of fibrinogen can result in severe bleeding, or arterial and venous thromboembolism, and poor wound healing. Dysfibrinogenemia is characterized by functional abnormalities of fibrinogen, which may be asymptomatic (in 50% of cases), or cause bleeding (25%) or thrombosis (25%). Replacement of the deficient or abnormal fibrinogen with frozen plasma, cryoprecipitate, or fibrinogen concentrate has been found to be effective in practice in treating haemostatic complications of these disorders. Although cryoprecipitate is the most commonly used replacement material, pathogen-reduced fibrinogen concentrates have several advantages, most importantly a lower potential risk of viral transmission and standardized fibrinogen content allowing accurate dosing. They also avoid transfusing unwanted clotting factors, platelet microparticles and immunoglobulins, and can be ad...Continue Reading

References

Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·M W Mosesson
Sep 27, 2006·Journal of Thrombosis and Haemostasis : JTH·R AsseltaM L Tenchini
Oct 7, 2009·Journal of Thrombosis and Haemostasis : JTH·M J Manco-JohnsonUNKNOWN FIBRINOGEN CONCENTRATE STUDY GROUP

❮ Previous
Next ❯

Citations

Apr 18, 2013·Best Practice & Research. Clinical Anaesthesiology·Kenichi A Tanaka, Daryl J Kor
Aug 9, 2013·Journal of Cardiothoracic and Vascular Anesthesia·Klaus GörlingerKenichi A Tanaka
Jan 8, 2011·Journal of Thrombosis and Haemostasis : JTH·Y Ozier, B J Hunt
Feb 18, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·E C Rodriguez-Merchan
Mar 31, 2015·Journal of Thrombosis and Haemostasis : JTH·A CasiniP de Moerloose
May 14, 2014·Transfusion·Jerrold H Levy, Lawrence T Goodnough
Nov 28, 2017·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·He CaiXiaohui Zhang
Jun 14, 2016·Expert Review of Hematology·Lucia StanciakovaJan Stasko
Jan 1, 2016·Terapevticheskiĭ arkhiv·E V YakovlevaN I Zozulya
Aug 23, 2020·The Veterinary Record·Conor O'HalloranDanielle Gunn-Moore

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.